It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Takeda applies for approval of Moderna's booster shots in Japan

National Nov 12, 2021

Takeda applies for approval of Moderna's booster shots in Japan

A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.

Regeneron antibody prevents COVID-19 infections for eight months

World Nov 9, 2021

Regeneron antibody prevents COVID-19 infections for eight months

by Elaine Chen

The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.

Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%

World / Science & Health Nov 5, 2021

Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%

by Robert Langreth

The drugmaker claims "overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people

World Oct 15, 2021

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people

If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.

AstraZeneca drug effective at treating mild COVID-19 symptoms in trial

World Oct 11, 2021

AstraZeneca drug effective at treating mild COVID-19 symptoms in trial

by Suzi Ring

The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.

Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor

World Oct 11, 2021

Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor

by Rebecca Robbins

Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

World Oct 8, 2021

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.

A Chilean tree holds hope for new vaccines — if supplies last

World / Science & Health | FOCUS Oct 7, 2021

A Chilean tree holds hope for new vaccines — if supplies last

by Aislinn Laing and Allison Martell

Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.

Pfizer COVID-19 shot safely bolsters antibodies in younger kids

World Sep 20, 2021

Pfizer COVID-19 shot safely bolsters antibodies in younger kids

In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.

Third man in Japan died after receiving recalled Moderna vaccine

National / Science & Health Sep 7, 2021

Third man in Japan died after receiving recalled Moderna vaccine

The 49-year-old man, who was allergic to buckwheat, received his second shot on Aug. 11 and his death was confirmed the following day.

Japan finds another Moderna vial suspected to contain foreign substance

National Sep 1, 2021

Japan finds another Moderna vial suspected to contain foreign substance

Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.

Foreign substances in Japan's Moderna shots: Here's what you need to know

National | EXPLAINER Aug 30, 2021

Foreign substances in Japan's Moderna shots: Here's what you need to know

by Osamu Tsukimori

Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.

« 1 … 10 11 12 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times